CollPlant Biotechnologies Ltd — Form SCHEDULE 13D/A
Filed October 8, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
This is an amended Schedule 13D/A filing by Sagy Ami regarding beneficial ownership in CollPlant Biotechnologies Ltd (Israeli biotech, ~$10.8M assets). The filing contains no substantive disclosure of the amendment's content—no share counts, percentages, transaction dates, consideration amounts, or description of what changed from the original filing. The document metadata only shows filing logistics.
Why this rating
Routine SEC amendment filing with no disclosed material facts, transactions, or ownership changes. Cannot assess materiality without substantive details.
See more from October 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.